$64.6 Million is the total value of Vida Ventures Advisors, LLC's 8 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plcordinary shares | $25,438,862 | +4.5% | 3,931,818 | 0.0% | 39.38% | +23.9% | |
| DYN | Dyne Therapeutics, Inc. | $19,891,505 | -20.4% | 2,220,034 | 0.0% | 30.79% | -5.6% | |
| ALLO | Allogene Therapeutics, Inc. | $5,700,177 | -36.2% | 1,798,163 | 0.0% | 8.82% | -24.4% | |
| KRON | Kronos Bio, Inc. | $3,594,908 | -24.4% | 2,765,314 | 0.0% | 5.56% | -10.4% | |
| LianBioordinary shares | $3,400,305 | -34.6% | 2,282,084 | 0.0% | 5.26% | -22.5% | ||
| KNTE | Kinnate Biopharma, Inc. | $3,090,881 | -53.8% | 2,207,772 | 0.0% | 4.78% | -45.2% | |
| PRAX | Praxis Precision Medicines, Inc. | $2,513,127 | +48.7% | 1,469,665 | 0.0% | 3.89% | +76.3% | |
| IKNA | New | Ikena Oncology, Inc. | $975,081 | – | 225,192 | +100.0% | 1.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-03
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Dyne Therapeutics, Inc. | 14 | Q4 2023 | 37.4% |
| Allogene Therapeutics, Inc. | 14 | Q4 2023 | 42.5% |
| Kinnate Biopharma, Inc. | 13 | Q4 2023 | 29.3% |
| Kronos Bio, Inc. | 13 | Q4 2023 | 20.4% |
| Praxis Precision Medicines, Inc. | 12 | Q3 2023 | 33.2% |
| Centessa Pharmaceuticals plc | 11 | Q4 2023 | 39.4% |
| LianBio | 9 | Q4 2023 | 12.1% |
| Homology Medicines, Inc. | 9 | Q3 2022 | 5.2% |
| Oyster Pt Pharma Inc | 5 | Q3 2021 | 10.3% |
| Assembly Biosciences, Inc. | 4 | Q2 2021 | 4.6% |
View Vida Ventures Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-12 |
| 13F-HR | 2024-01-05 |
| 13F-HR | 2023-10-03 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-04-13 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-10-05 |
| 13F-HR | 2022-07-15 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-10 |
View Vida Ventures Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.